Business Development, co-founder at Xinvento B.V. - Amsterdam, North Holland, Netherlands
Developing treatments for tomorrow, to improve lives today.At Xinvento (zin-ven-toh), our aim is to positively impact the lives of those living with congenital hyperinsulinism.Our research and development will provide a credible alternative treatment for congenital hyperinsulinism, improving accessibility to modern medicine for patients.By alleviating the difficulties associated with the disease, we will enhance the quality of life for both patients and carers, freeing up time for families to focus on the more enjoyable parts of life.